J. Huth

Ali et al reported last year (J Nucl Med 28(4): 628–629) no correlation between bone loss in leuprolide or danazol therapy, conflicting previous reports showing a correlation. We report the preliminary results on 6 patients ages 31–46 studi…

The resumption of cyclic uterine bleeding reportedly accompanies the use of human prolactin (HPRL)-suppressing agents in postpill galactorrhea-amenorrhea. In this laboratory, HPRL suppression with L-dopa was variable and short lived. Basal …